🇺🇸 FDA
Patent

US 7772387

Oligonucleotides comprising a modified or non-natural nucleobase

granted A61KA61K31/7115

Quick answer

US patent 7772387 (Oligonucleotides comprising a modified or non-natural nucleobase) held by Alnylam Pharmaceuticals, Inc. expires Mon Aug 05 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Alnylam Pharmaceuticals, Inc.
Grant date
Tue Aug 10 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 05 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K31/7115